Testing effectiveness (Phase 2)UnknownNCT00003327What this trial is testingPaclitaxel in Treating Patients With Recurrent or Refractory Head and Neck CancerWho this might be right forHead and Neck Cancer Theradex 60
Testing effectiveness (Phase 2)Study completedNCT03370276What this trial is testingCetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaWho this might be right forSquamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the Oral Cavity+5 more H. Lee Moffitt Cancer Center and Research Institute 95
Testing effectiveness (Phase 2)Ended earlyNCT02196168What this trial is testingCisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+26 more National Cancer Institute (NCI) 6
Large-scale testing (Phase 3)Study completedNCT00964977What this trial is testingEffectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.Who this might be right forOropharyngeal CancerOral CancerLymph Node Metastasis Johannes Gutenberg University Mainz 209
Testing effectiveness (Phase 2)Looking for participantsNCT05136196What this trial is testingBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more National Cancer Institute (NCI)
Not applicableUnknownNCT00415298What this trial is testingAP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer University of California, San Diego 12
Testing effectiveness (Phase 2)Study completedNCT00021047What this trial is testingEpirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorWho this might be right forEsophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more National Institutes of Health Clinical Center (CC)
Not applicableLooking for participantsNCT06356272What this trial is testingOropharynx (OPX) Biomarker TrialWho this might be right forClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Oropharyngeal Squamous Cell Carcinoma+8 more Mayo Clinic 560
Testing effectiveness (Phase 2)Study completedNCT02508389What this trial is testingThe Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck CancerWho this might be right forRadiation Induced Oral Mucositis Galera Therapeutics, Inc. 223
Early research (Phase 1)Study completedNCT00470496What this trial is testingPhotodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerWho this might be right forRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT02123511What this trial is testingAcetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation TherapyWho this might be right forMucositisOral ComplicationsRecurrent Adenoid Cystic Carcinoma of the Oral Cavity+80 more Mayo Clinic 34
Not applicableStudy completedNCT04696744What this trial is testingProspective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx)Who this might be right forCirculating Tumor CellOropharyngeal Cancer Hospices Civils de Lyon 12
Not applicableStudy completedNCT00482872What this trial is testingGermline Mutations in Patients With Head and Neck Cancer and a Family History of CancerWho this might be right forHead and Neck Cancer Vanderbilt University Medical Center 400
Testing effectiveness (Phase 2)Ended earlyNCT00646659What this trial is testingCetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By SurgeryWho this might be right forHead and Neck Cancer European Organisation for Research and Treatment of Cancer - EORTC 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Study completedNCT00503997What this trial is testingPemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 42
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00509665What this trial is testingGemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck CancerWho this might be right forHead and Neck Cancer Medical University of South Carolina 18
Not applicableStudy completedNCT01466257What this trial is testingBiomarkers in Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer ECOG-ACRIN Cancer Research Group 70
Early research (Phase 1)Study completedNCT00066651What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced Solid TumorsWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)